Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionQrg Capital Management, Inc.
Latest Disclosed Ownership60,327 shares
Latest Disclosed Value $ 4,831,011
Qrg Capital Management, Inc. reports 10.76% increase in ownership of EW / Edwards Lifesciences Corporation

On April 27, 2026 - Qrg Capital Management, Inc. filed a 13F-HR form disclosing ownership of 60,327 shares of Edwards Lifesciences Corporation (MX:EW) valued at $4,831,011 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 54,464 shares of Edwards Lifesciences Corporation. This represents a change in shares of 10.76% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 60,327 5,863 10.76 4,831 4.05 0.0499
2026-02-02 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 54,464 18,172 50.07 4,643 64.53 0.0517
2025-10-28 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 36,292 -3,946 -9.81 2,822 -10.33 0.0342
2025-07-21 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 40,238 -43,056 -51.69 3,147 -47.87 0.0275
2025-04-17 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 83,294 5,992 7.75 6,037 5.51 0.0626
2025-02-05 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 77,302 57 0.07 5,723 12.26 0.0589
2024-10-30 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 77,245 30,892 66.65 5,097 19.06 0.0551
2024-07-12 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 46,353 1,898 4.27 4,282 0.78 0.0508
2024-05-07 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 44,455 -5,189 -10.45 4,248 12.23 0.0539
2024-02-07 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 49,644 2,939 6.29 3,785 17.00 0.0561
2023-11-13 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 46,705 46,705 3,236 0.0561
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.